About Glycosaminoglycan xylosylkinase
Glycosaminoglycan xylosylkinase (FAM20B) is a protein
from Homo sapiens identified by UniProt accession
O75063, 409 residues long.
MolForge cross-references it against 0 known binders and
89 disease associations.
Target properties
| Protein name | Glycosaminoglycan xylosylkinase |
| UniProt accession | O75063 |
| Gene | FAM20B |
| Organism | Homo sapiens |
| Length | 409 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (89)
Diseases linked to this target (Open Targets).
- body height · score 0.21
- Coxa vara · score 0.07
- Coxa Vara · score 0.07
- Gollop-Wolfgang complex · score 0.07
- arterial stiffness measurement · score 0.06
- fibular aplasia-ectrodactyly syndrome · score 0.06
- tibia, hypoplasia or aplasia of, with polydactyly · score 0.06
- Blount disease · score 0.06
- metaphyseal anadysplasia · score 0.06
- tibial hemimelia · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75063-F1 | alphafold | PREDICTED | 93.18 | — |
Amino-acid sequence (409 residues)
MKLKQRVVLL AILLVIFIFT KVFLIDNLDT SAANREDQRA FHRMMTGLRV ELAPKLDHTL QSPWEIAAQW VVPREVYPEE TPELGAVMHA MATKKIIKAD VGYKGTQLKA LLILEGGQKV VFKPKRYSRD HVVEGEPYAG YDRHNAEVAA FHLDRILGFH RAPLVVGRFV NLRTEIKPVA TEQLLSTFLT VGNNTCFYGK CYYCRETEPA CADGDIMEGS VTLWLPDVWP LQKHRHPWGR TYREGKLARW EYDESYCDAV KKTSPYDSGP RLLDIIDTAV FDYLIGNADR HHYESFQDDE GASMLILLDN AKSFGNPSLD ERSILAPLYQ CCIIRVSTWN RLNYLKNGVL KSALKSAMAH DPISPVLSDP HLDAVDQRLL SVLATVKQCT DQFGMDTVLV EDRMPLSHL
Explore Glycosaminoglycan xylosylkinase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets